Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages

Abstract

Purinergic receptors of the P2 class are cell surface receptors which are sensitive to extracellular adenine nucleotides, such as ATP and ADP. This class of receptors is divided into the P2Y family of G protein-coupled receptors and the P2X family of ligand-gated ion channels. The P2X receptors, seven of which have been cloned, are thought to possess two transmembrane domains and function as multimeric complexes. Numerous studies have suggested a role for P2 receptors in activation of macrophages by Gram-negative bacterial endotoxin (lipopolysaccharide; LPS). LPS is thought to exert its toxic effects, in large part, by inducing macrophages to release inflammatory mediators such as tumor necrosis factor α (TNFα), interleukin-1 (IL-1) and nitric oxide (NO). Although multiple signal transduction pathways are activated by LPS in macrophages, the proximal mechanisms by which LPS exerts these effects remain unclear. The current study examines the role of the P2X₇/P2Z purinergic receptor in LPS signaling events and in nitric oxide (NO) production. The results indicate that the P2X₇ receptor is required for maximal LPS activation of the mitogenactivated protein (MAP) kinases extracellular signal-regulated kinase (ERK)1 and ERK2, for activation of nuclear factor (NF)-κB, as well as for upregulation of the inducible form of nitric oxide synthase (iNOS). These results are fortified by our recent observation that the C-terminus of the P2X₇ receptor is homologous to conserved LPS binding domains of proteins critical to host responses to Gram-negative bacterial infection, such as LPS-binding protein (LBP) and bactericidal permeability-increasing protein (BPI). Taken together, these observations suggest that the P2X₇ receptor plays a fundamental role in LPS signal transduction and activation of macrophages, and thus may represent a therapeutic target for Gram-negative bacterial septicemia.

References

Morrison DC , Ryan JL Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417—432.

Sweet MJ , Hume DA Endotoxin signal transduction in macrophages. J Leukoc Biol 1996; 60: 8—26.

Nathan CF , Hibbs Jr JB Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65—70.

Ferrari D. , Chiozzi P. , Falzoni S. , Hanau S. , Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 1997; 185: 579—582.

Tonetti M. , Sturla L. , Giovine M. , Benatti U. , De Flora A. Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 1995; 214: 125—130.

Tanke T. , van de Loo JW , Rhim H. , Levethal PS , Proctor RA , Bertics PJ Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J 1991; 277: 379—385.

Denlinger LC , Fisette PL , Garis KA et al. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996; 271: 337—342.

Proctor RA , Denlinger LC , Leventhal PS et al. Protection of mice from endotoxic death by 2-methylthio-ATP . Proc Natl Acad Sci USA 1994. 91: 6017—1620.

Surprenant A. , Rassendren F. , Kawashima E. , North RA , Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272: 735—738.

10.

Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today 1995; 16: 524—528.

11.

Murgia M. , Hanau S. , Pizzo P. , Rippa M. , Di Virgilio F. Oxidized Atp. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem 1993; 268: 8199—8203.

12.

Humphreys BD , Dubyak GR Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J Immunol 1996; 157: 5627—5637.

13.

Hu Y. , Fisette PL , Denlinger LC et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998; 273: 27170—27175.

14.

Denlinger LC , Garis KA , Sommer JA , Guadarrama AG , Proctor RA , Bertics PJ Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun 1997; 66: 1638—1647.

15.

Corbett JA , Kwon G. , Misko TP , McDaniel ML Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans. Am J Physiol 1994; 267: C48—54.

16.

Denizot F. , Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271—277.

17.

Goldring CE , Narayannan R. , Lagadec P. , Jeannin JF Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappaB/Rel proteins . Biochem Biophys Res Commun 1995; 209: 73—79.

18.

Kim YM , Lee BS , Yi KY , Paik SG Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997; 236: 655—660.

19.

Ferrari D. , Wesselborg S. , Bauer Mka , Schulze-OsthoffK. Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively tageting NF-kappaB p65. J Cell Biol 1997; 139: 163 5-643.